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como ingreso, tipo de ocupación y nivel educacional siguen explicando en algún 
grado la desigualdad observada en salud en esta población.
PCV39
ExPloring gEndEr diffErEnCEs in PoPulation-BasEd PrEValEnCEs of 
CardioVasCular disEasEs in ChilE aftEr thE hEalth CarE rEform of 
2005
Dressler C.1, Cabieses B.2
1University of York, York, UK, 2Universidad del Desarrollo, Santiago, Chile
Objectives: Cardiovascular diseases (CVDs) are the biggest killer worldwide. Since 
2002 the Cardiovascular Health Program exists in Chile and more people with CVDs 
are treated over time. Few focused evaluations of the equity-centered health care 
reform of 2005 in Chile have been conducted and none of them with a gender focus. 
We aimed at analysing the existence of gender differences in the prevalence of CVDs 
in Chile after this reform. MethOds: Secondary analysis of the cross-sectional 
Chilean Health Survey 2009-2010 (downloaded after approval from the Ministry of 
Health in Chile; n= 5293 adult participants). We explored the relationship between 
CVDs (hypertension and myocardial infarction) and gender (male/female), crude 
and adjusted by potential confounders (individual health-risk factors, demograph-
ics, socioeconomic status, health care provision). Odds Ratios (OR) were estimated 
by weighted logistic regressions in Stata 12.0. Results: The crude prevalence of 
hypertensions were 28.13% (95%CI [26.11-30.24]) and myocardial infarcts 3.19% (95%CI 
[2.47-4.12]). More than half of the population were overweight/obese (39.20%/22.92%) 
and any alcohol consumption in the past month was high (58.42%). Around 40.19% 
currently smoke. Regression models indicated that gender was a significant risk fac-
tors for hypertensions (OR 1.58, 95% CI: 1.23-2.03) as well as having public health care 
insurance (OR1.45, 95% CI: 1.01-2.10). However, gender was not a significant predictor 
of myocardial infarcts, whereas age (OR 1.05, 95% CI: 1.03-1.06) and body mass index 
(OR 1.05, 95% CI: 1.02-1.09) were significant to this condition. cOnclusiOns: This is 
the first study on gender patterns of CVDs after health care reform of 2005 in Chile. It 
uses a national representative survey and it controls for relevant confounders. Results 
suggest that men were less likely to report hypertension than women. This raises 
the hypothesis of whether men are being underdiagnosed and whether current CVD 
programmes in Chile need to attract men that are not defining themselves as sick.
PCV40
trEatmEnt PattErns of atrial fiBrillation (af) in latin amEriCa
Leyva-Bravo V.1, Soriano M.A.1, González-Rojas G.L.1, Nieto W.J.2, Novo F.A.3, Guerrero M.L.4
1IMS Health, Mexico City, Mexico, 2Sanatorio de la Trinidad San Isidro, Buenos Aires, Argentina, 
3Hospital Alemán, Buenos Aires, Argentina, 4Servicio Medico de la Direccion Ejecutiva de La 
Magistratura (D.E.M.) Tribunal Supremo de Justicia, Caracas, Venezuela
Objectives: Atrial Fibrillation (AF) is the most common chronic arrhythmia occur-
ring worldwide in the presence of other cardiovascular disease. The objective of the 
current study is to determine real-life treatment patterns for patients with AF in 
Latin America. MethOds: We conducted 59 face-to-face interviews with cardiolo-
gists in four Latin American countries--Argentina, Brazil, Chile and Venezuela-- to 
assess medical treatment. Information from 240 patients from private and public 
institutions was evaluated using CHADS2 scores to identify patients’ risk and to 
determine treatment. Results: Patients with AF undergo a 3-step process to define 
their treatment course: 1) AF evaluation and diagnosis; 2) AF classification: paroxys-
mal, persistent, and permanent; 3) Clinical treatment focused on stroke prevention 
based on symptom relief, optimal treatment of concomitant cardiovascular disease, 
rate control and correction of rhythm disturbance. Overall in all four countries, 
analysis shows that the majority of patients with AF were diagnosed right before 
or at the time of first stroke. The most common type of AF was permanent, except 
in Chile which was paroxysmal. The preferred antiarrythmic was amiodarone; 
the primary vitamin K antagonist used was warfarin in Brazil and Venezuela and 
acenocumarol in Argentina and Chile. cOnclusiOns: Results from the study sug-
gest that there are no significant differences among countries and that the majority 
treat patients following international clinical guidelines. Although the individual 
health care systems need to be considered in terms of relationship of treatment 
patterns with resource use, it is reassuring to note that international standards of 
care are being embraced in major emerging markets.
indiVidual’s hEalth – Clinical outcomes studies
Pih1
análisE ComParatiVa dos antiConCEPCionais orais Com difErEntEs 
ConCEntraçoEs dE EtinilEstradiol Em rElação aos PErfis dE EfiCáCia 
E dE adEsão
Freitas M.G., Silva A.S., Elias F.T.S.
Brazilian Ministry of Health, Brasilia, Brazil
ObjetivOs: Analisar as evidências científicas disponíveis sobre anticon-
cepcional oral com apresentação farmacêutica Etinilestradiol (EE) 20mcg + 
Levonorgestrel (LVG) 100mcg, em comparação com a preparação EE 30mcg + 
LVG 150mcg. MétOdOs: Foi realizada ampla busca nas bases de dados Medline 
(via Pubmed), Cochrane Library, Rebrats e CRD. ResultAdOs: Dos 53 estudos 
encontrados na estratégia de busca, apenas uma RS disponível na base de dados 
The Cochrane Library foi selecionada por apresentar resultados comparados dos 
mesmos princípios ativos nas dosagens relacionadas à pergunta do estudo. Na 
RS foram incluídos 21 ECRs, comparando contraceptivos orais combinados com 
doses de estrógenos maiores ou menores/iguais a 20 µg. Não houve diferenças 
significativas em termos de eficácia contraceptiva entre os 13 diferentes anticon-
cepcionais. Encontrou-se risco elevado de distúrbios de sangramento para os ACO 
de baixa dose de estrógeno (amenorréia ou sangramento irregular, infrequente 
ou prolongado; sangramento frequente e spotting). Mulheres em uso de EE 20 µg 
e desogestrel 150 µg foram mais suscetíveis a sofrer sangramento irregular (OR 
1.56; 95% IC 1.10 a 2.20) e a ter maior duração do sangramento irregular durante 
o terceiro ciclo (diferença média de 0.7 dias; 95% IC 0.30 a 1.10) que mulheres em 
in both developed and emerging settings. As Mexico’s economy continues to grow, 
the value of investments in health innovation from both a public health and eco-
nomic perspective will rise.
PCV36
EValuation of homE mEdiCation rEViEw in Community out rEaCh 
Program
Naik V.1, Nagappa A.N.2, Prabhu N.1, Reddy K.1
1Manipal Univiersity, Manipal, India, 2Manipal University, MCOPS, Manipal, India
Objectives: To Establish the value of WHO-FIP Pharmacuetical Care in chronic 
conditions like diabetes, Hypertnsion and Obesity in a community out reach pro-
gram. The Pharmaceutical Care program is new concept proposed in 2005, to aid 
the patient in improving his knowledge in the area of Drug, Disease and Life style 
by pharmacist. MethOds: The patients are approched at thier homes by a panel of 
health care professionals led by pharmacists. the pharmacist after interacting with 
the patients make the documentation regarding patient current status of knowl-
egde, regarding disease, drugs and life style along with his/her condition of health 
and the life style. The care plan is made by taking into above facts and patients are 
explained the correct way of using the medicine, the correct life style habits and 
idea about diet and physical activity. The patients were again approched after a 
fortnight at thier homes and measurements of Blood pressure, Body Mass Index 
along with Random blood sugar were carried out . All these values are recorded in 
a Pharmacuetical care card, which was issued to individual patients. The patients 
were usually followed upto 3 months in which minimum 6 visits have beed carried 
out. Results: The patients are able to asses the progress of thier condition by fol-
lowing the advice of a health care professional. cOnclusiOns: It is expected that 
patient will under go a cycle of knowlegde attitude and practice model. For assesing 
the value of the program, the pre and post evaluation by EQ 5D questionnaire and 
clinical parameters will be applied.
PCV37
EVoluCión En El uruguay dE tazas dE utilizaCión dE CatEtErismo 
CardíaCo diagnostiCo Par a CardioPatía Congénita En mEnorEs dE 18 
años (1995-2012)
Lombide I., Morales M., Fernandez G., Saona G., Perna A., Gambogi R., Gamboa R.
Fondo Nacional de Recursos, Montevideo, Uruguay
ObjectivOs: Como resultado del advenimiento del ecocardiograma doppler 
color ( EDC) a fines de los 90, muchas cardiopatías congénitas ( CC) son tratadas 
sin Cateterismo cardíaco Diagnóstico (CCD). En el Uruguay el Fondo Nacional de 
Recursos financia CCD desde 1981, estando normatizada su autorización desde el 
2008. Se cuenta con un registro único nacional de CCD. Objetivos: Conocer la evolución 
de la tasa de utilización de CCD en población pediátrica, períodos: 1°:1995 – 1999, 
2º:2003 - 2007, 3º: 2008 - 2012. MetOdOlOgíAs: Estudio descriptivo de solicitudes de 
CCD para CC en menores de 18 años.Las variables analizadas son : año de solicitud, 
edad, sexo, procedencia, cobertura asistencial, estado de autorización, y población 
nacional discriminada por edad en forma anual. Para analizar la evolución temporal 
de las tasas de solicitudes ajustada por edad y sexo se utilizó una regresión Binomial 
Negativa. ResultAdOs: Se observó un descenso significativo de la tasa de solicitudes 
en el devenir de los períodos analizados (RR= 0,93 IC95%= 0,91 - 0,95). Analizada la 
tendencia temporal y tomando como referencia el primer período se observa un 
descenso significativo en las tasas de solicitudes del segundo y tercer período ( RR= 
0,55 IC95%= 0,43 - 0,70 y RR = 0,37 IC95%= 0,29 - 0,47). Al tomar como referencia 
el segundo período, se observa un descenso significativo en el tercer período ( RR 
= 0,67 IC95%= 0.52- 0,85). cOnclusiOnes: El mayor descenso del número de CCD 
observado en el tercer período podría atribuirse a la introducción de normativas para 
autorizar la cobertura financiera de CCD por parte del FNR sumado al protagonismo 
del EDC. La utilización de la normativa resultó una herramienta útil para disminuir el 
uso de procedimientos innecesarios, optimizando la utilización de recursos.
PCV38
dEsigualdad En salud rElatiVa al ingrEso En ChilE: análisis dE 
dEsComPosiCión dEl índiCE dE ConCEntraCión En hiPErtEnsión, 
diaBEtEs y dEPrEsión
Cabieses B.1, Espinoza M.A.2
1Universidad del Desarrollo, Santiago, Chile, 2Pontificia Universidad Católica de Chile, Santiago, 
Chile
ObjectivOs: Existe una clara asociación positiva entre ingreso per cápita y salud. 
Sin embargo, esta asociación no es tan clara cuando el Producto Interno Bruto per-
cápita (PIBpc) supera de los US$18,000. Esta pérdida de asociación es en buena 
parte explicada por las grandes diferencias de resultados en salud entre subgrupos 
de la población, donde uno de sus determinantes más claramente establecidos 
es el ingreso económico. Chile es un país en vías de desarrollo que pretende lle-
gar el año 2018 a un PIBpc > US$18,000. Toda evaluación de políticas en salud no 
debe estar circunscrita a promedios poblacionales sino a la distribución de dichos 
resultados en la población. El objetivo de este estudio fue estudiar la desigualdad 
en salud relativa al ingreso en Chile para tres enfermedades de alta prevalencia: 
hipertensión, diabetes y depresión. MetOdOlOgíAs: A partir de la encuesta CASEN 
del 2009 (n= 246 924), se estimó el índice de concentración de Erreygers (ICErreygers) 
para cada una de estas enfermedades y se realizó su descomposición basado en 
una regresión probit para estudiar factores asociados legítimos (edad, sexo, estado 
marital, número de miembros del hogar, etnia, rural/urbano) e ilegítimos (ingreso, 
ocupación, educación, calidad de vivienda, previsión de salud). ResultAdOs: El 
ICErreygers estimado para hipertensión, diabetes y depresión fue de 0,0030; 0,0037 y 
-0,0012, respectivamente. La descomposición de ICErreygers indica que la mayor parte 
de la desigualdad está explicada por la edad en todos los casos (legítimo). Ingreso 
y ocupación le siguieron de manera consistente en los tres problemas de salud 
estudiados (ilegítimos). cOnclusiOnes: La desigualdad en salud relativa al ingreso 
en hipertensión, diabetes y depresión en Chile muestra estar fundamentalmente 
explicada por factores legítimos como la edad. Sin embargo, factores ilegítimos 
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guías de práctica clínica y la farmacopea Pediadosis. La información se sistema-
tizó y analizó utilizando Epi Info versión 3.5.1 para Windows, se obtuvo estadística 
descriptiva. ResultAdOs: El 80.3% de los pacientes recibió antibióticos (n= 122). 
La media de antibióticos prescritos fue 1.8, en un intervalo de 1-4, la moda fue 2. 
Diagnósticos más frecuentes: gastroenteritis 16.4% y bronconeumonía 9.8%. Uso 
de los antibióticos: profiláctico 2% y terapéutico 98%. Antibióticos más frecuentes: 
amikacina 37.4%, ampicilina 25.6% y dicloxacilina 13.7%. Vía de administración más 
frecuente: intravenosa 87%. La calidad de la prescripción fue inadecuada en 93%. 
Errores de prescripción más frecuentes (individuales): duración inadecuada 79.9%, 
dosis inadecuada 63% y medicamento inadecuado 57.5%. cOnclusiOnes: La cali-
dad de prescripción de antibióticos en la unidad médica es preponderantemente 
inadecuada, se requieren estretegias de intervención educativas y gerenciales para 
dar solución al problema. Se sugiere evaluar la calidad de prescripción de otros 
grupos de medicamentos en todos los servicios médicos del hospital.
indiVidual’s hEalth – Cost studies
Pih5
análisis dE imPaCto PrEsuPuEstal dEl uso dE lng siu Como método dE 
ContraCEPCión En ColomBia
Acero G., Romero M.
Fundacion Salutia, Bogotá, Colombia
ObjectivOs: Analizar el impacto presupuestal de incorporar el Sistema 
Intrauterino Liberador de Levonorgestrel (SIU-LNG) en el sistema de salud colombi-
ano como método de contracepción reversible de larga duración. MetOdOlOgíAs: 
Tomando como referencia un modelo de costo-efectividad que muestra el benefi-
cio del uso de SIU-LNG, se realizó un modelo de impacto presupuestal de la adición 
del SIU-LNG al sistema de salud. Tomando como referencia la población estimada 
en Colombia para 2012 y los datos de uso de estos métodos de planificación de 
la Encuesta Nacional de Demografía y Salud 2010, se estimó el impacto para una 
cohorte fija y con incremento poblacional del uso del SIU-LNG con una tasa de 
reemplazo anual del 30%, hasta 5 años, incluyendo costos directos de salud. Se 
realizó un análisis de sensibilidad univariado, realizando variaciones en la tasa de 
remplazo. ResultAdOs: El impacto que tendría SIU-LNG para el sistema de salud 
como método de contracepción usando cohorte fija sería de USD$ 30.422.297,03 
(USD$ 0,65 per cápita) en el primer año, disminuyendo anualmente hasta llegar a 
un impacto acumulado de USD$ 0,31 per cápita a 5 años. Con incrementos anuales 
de población similar a la tasa de crecimiento poblacional, el impacto acumulado 
al quinto año sería de USD$ 0,42 per cápita, correspondiente a USD$ 19.969.830,10. 
Tomando como referencia el valor per cápita asignado para 2012, éste implicaría 
un impacto de 0,21% para el primer año, de -0,02% y -0,03% para el segundo año en 
cohorte móvil o fija, respectivamente. cOnclusiOnes: Los resultados muestran 
que la incorporación de SIU-LNG como método de planificación en el sistema de 
salud colombiano genera ahorro en el gasto a partir del segundo año en las con-
diciones del caso analizado y su impacto es bajo frente a los beneficios en calidad 
de vida que podría generar.
Pih6
a timE-motion ComParison of itEmizEd trEatmEnt Costs in first 
VErsus suBsEquEnt CyClEs of in Vitro fErtilization (iVf): trEatmEnts 
Can oPtimizEd for imProVing outComEs whilE inCrEasing PatiEnt 
VolumEs in Cost-ConstrainEd rEgions
Jones C.1, Carpinello O.1, Erten M.Z.1, Sills E.S.2
1University of Vermont - College of Medicine, Burlington, VT, USA, 2Pacific Reproductive Center, 
Irvine, CA, USA
Objectives: To anlayze the differences in initial versus subsequent fresh in vitro 
fertilization (IVF) cycles with regard to personnel time, consumables and other 
resources. MethOds: A cross-sectional observational study of 120 patients. 
Observations were made during regular clinic hours in the clinical rooms of a UK 
fertility centre and its affiliated embryology department from January 1, 2002 to 
December 31, 2002. The average time per task was determined for each component 
of treatment by averaging the observed duration for five distinct observations. For 
each member of staff and each component of treatment, the total time (in hours) 
was estimated by multiplying the duration of attendance by a) the percentage of 
patients undergoing each treatment component and b) the frequency of attend-
ance by each staff member, which allowed for the weighted average of personnel 
time and costs along with standard deviations to be calculated. Results: When 
consumables were included, each initial cycle cost the clinic approximately £2246.57 
+/- £151.01. The total amount of time patients spent with staff during subsequent 
fresh IVF cycles was much less than initial cycles, at 6.94 +/- 2.44 hours. The time 
spent with staff equated to £257.53 +/- £90.77, while each subsequent fresh cycle 
cost the clinic approximately £1813.12 +/- £90.77. A total of 9.77 +/- 4.94 more staffing 
hours were spent with patients during initial IVF cycles compared to subsequent 
fresh IVF cycles. This decrease in staffing time created a £319.52 +/- £176.19 dif-
ference between initial and subsequent fresh cycles, while the diminished use of 
consumables on subsequent treatment cycles accounted for a cost-reduction of 
£113.93. Thus, subsequent fresh IVF cycles were, on average, £433.45 +/- £176.19 
less than initial cycles. cOnclusiOns: The details of our study give insight, par-
ticularly in cost-constrained regions, how clinic management may be conducted 
in a cost-efficient manner.
Pih7
Costo-EfECtiVidad dE CarBEtoCina En ComParaCión Con oxitoCina 
Para PrEVEnir hEmorragia PosParto Por atonía utErina En PaCiEntEs 
Con faCtorEs dE riEsgo En ColomBia
Rueda C., Caceres L.A., Caicedo Navas A.G.
Independiente, Bogotá, Colombia
ObjectivOs: La hemorragia postparto (HPP) es la principal causa de mortali-
dad materna, el 75% de los casos de HPP son causados por atonía uterina, por lo 
uso de EE 30 µg e desogestrel 150 µg (Akerlund, 1993). Muitos ACO contendo baixa 
dose de estrógeno resultaram em altas taxas de descontinuação (global e através 
de eventos adversos como sangramento irregular). Mulheres em uso de EE 20 µg 
e desogestrel 150 µg tiveram um OR de descontinuação através de sangramento 
irregular igual a 2.59 (95% IC 1.35 a 5.00) em relação ao grupo de mulheres em uso 
de EE 30 µg e desogrestrel 150 µg (Akerlund 1993). cOnclusões: Reduzir a con-
centração de estrógenos para melhorar a segurança pode resultar em baixa adesão 
em função de mudanças inaceitáveis nos padrões de sangramento.
Pih2
Cost EffECtiVEnEss EValuation of a rotaVirus VaCCination Program 
in argEntina
Garcia Marti S.1, Alcaraz A.2, Valanzasca P.3, Mc mullen M.1, Standaert A.4, Garay U.5,  
Lepetic A.C.6, Gomez J.A.7
1Institute for Clinical Effectiveness and Health Policy, Buenos Aires, Argentina, 2Institute 
for Clinical Effectiveness and Health Policy (IECS), Buenos Aires, Argentina, 3Institute for 
Clinical Effectiveness and Health Policy (IECS), CABA, Argentina, 4GlaxoSmithKline, Wavre, 
Belgium, 5IECS Institute for Clinical Effectiveness and Health Policy, Buenos Aires, Argentina, 
6GlaxoSmithKline, Buenos Aires, Argentina, 7GlaxoSmithKline, Victoria, Argentina
Objectives: Rotavirus diarrhea is one of the most important vaccine-preventable 
causes of severe diarrhea in children worldwide. There are two vaccines licensed 
Rotarix® (monovalent attenuated human rotavirus strain) by GlaxoSmithKline and 
RotaTeq® (pentavalent live human-bovine reassortant vaccine) by MSD with simi-
lar results. This study aim was to evaluate the cost-effectiveness of incorporating 
monovalent rotavirus vaccine 2-dose scheme (Rotarix®) compared with the penta-
valent vaccine 3-dose scheme (Rota-Teq®) in the national immunization schedule 
of Argentina. MethOds: A deterministic Markov model based on the lifetime fol-
low up of a birth cohort was used. QALYs as an effect measure, health care sys-
tem perspective and a 5% discount rate for health benefits and costs have been 
used. A review of the literature to obtain epidemiologic and resources utilization 
data was performed. The sources used to estimate the epidemiologic parameters 
were the National Health Surveillance System, the national mortality statistics 
and national database of hospital discharges records. Costs are expressed in local 
currency. PAHO 2012 Revolving Fund vaccine prices were used. Results: Rotarix® 
prevented 177,254 rotavirus cases, 19,376 hospitalizations and 31 deaths while 
Rotateq® prevented 165,022, 17,882 and 28 events respectively. Both vaccination 
strategies were less costly and more effective than the strategy without vaccination 
(total costs $69,700,645 and 2,575 total QALYs lost). When comparing vaccination 
schemes Rotarix® was less expensive ($ 60,174,508 vs. $ 67,545,991 total costs) and 
more effective (1,105 vs. 1,213 total QALYs lost) than Rotateq®, being the dominating 
strategy. Probabilistic sensitivity analysis showed results to be robust of being cost-
effective at a WTP threshold of 1 GDP per capita when comparing the 2-dose scheme 
vs. no vaccination or the 3-dose scheme one. cOnclusiOns: In Argentina both 
rotavirus vaccination schemes dominate the no vaccination strategy and Rotateq® 
(3-dose scheme) was dominated by Rotarix® (2-dose scheme), being this results 
robust in the sensitivity analysis.
Pih3
rolE of antioxidants in rECurrEnt PrEgnanCy lossEs, low Birth 
wEight, and gEstational duration
Bhatti T.A.
Health Services Academy, Islamabad, Pakistan
Objectives: To study the impact of antioxidants on the maternal and child health 
of women with Recurrent Pregnancy Loss (RPL) and healthy pregnancies. The three 
main variables studied for the purpose included (i) low birth weight (LBW), (ii) ges-
tational duration (GD) and (iii) RPL with a history of RPL. MethOds: The study was 
conducted in two parts. Study 1 focused on the impact of antioxidants on mothers 
with RPL with a sample size of 123 mothers out of 200 cases. Study 2 focused on 
the impact of antioxidants on LBW and GD included a sample of 900 women with 
healthy pregnancy of 6 months. Each of the study groups were divided in to experi-
mental (active arm) and control group (placebo arm). It was hypothesized that 1) 
Oral antioxidant supplementation will reduce the rate of recurrent pregnancy loss; 
2) Oral supplementation of antioxidants during pregnancy will increase the birth 
weight of the child; and 3) Oral supplementation of antioxidants will decrease pre-
mature births. Results: it was found in study 1 that antioxidant supplementation 
reduced the chances of RPL as the chances of conception in women in the active 
arm increased by 36%. Study 2 revealed that the chance of LBW was reduced by 
15% in women that received antioxidant supplements and the average weight of 
their infants in the active arm increased by 0.30kg. It was found that the gestational 
period for women in the active arm increased by 12 days and they were 30 times 
more likely to give birth within their expected date of delivery (EDD). Lastly, it was 
also found that maternal and neonatal mortality was also reduced by 4.4% and 2.9% 
respectively. cOnclusiOns: It is conclusion that antioxidants be made mandatory 
for normal pregnant women and especially women of RPL.
Pih4
Calidad dE PrEsCriPCión dE antiBiótiCos En El sErViCio dE PEdiatria 
dE un hosPital gEnEral dE CardEnas, taBasCo, méxiCo
Zavala-González M.A.1, Sánchez-Santana R.2
1Consultor Independiente, Cárdenas, Tabasco, Mexico, 2Secretaría de Salud del Estado de Tabasco, 
Cárdenas, Tabasco, Mexico
ObjectivOs: Evaluar la calidad de la prescripción de antibióticos en el ser-
vicio de pediatría del Hospital General de Cárdenas, Tabasco, México, en el año 
2010. MetOdOlOgíAs: Estudio de utilización de medicamentos, de tipo transversal. 
Se estudió un universo de N= 678 expedientes de pacientes atendidos durante 2010, 
se tomó una muestra probabilística simple (p= 0.15, d= 0.05, Z= 1.6) de n= 152 expedi-
entes seleccionados sistemáticamente a intervalos de k= 5. Se recopiló información 
sobre antibióticos prescritos, diagnóstico, uso del antibiótico y esquema terapéutico; 
se evaluó la calidad de la prescripción comparando el esquema prescrito contra las 
